Literature DB >> 17854058

A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.

Anna Johansson1, Jonathan Jones, Kristian Pietras, Sigrid Kilter, Asa Skytt, Stina Häggström Rudolfsson, Anders Bergh.   

Abstract

BACKGROUND: Castration results in a major involution of the normal prostate gland. This process is initiated by effects in the prostate stroma and vasculature. Castration-induced regression of androgen sensitive prostate tumors is however less prominent and hypothetically this could be related to a limited stromal/vascular response. We therefore used animal tumor models to explore the importance of stroma and vascular effects, and if castration effects could be enhanced by a simultaneous therapy targeting the tumor stroma.
METHODS: Using rats with Dunning PAP and H tumors, stereological methods, immunohistochemistry, and Western blotting, we studied the tumor response 7 and 28 days after castration and after the addition of stroma targeted therapies.
RESULTS: In the normal ventral prostate (VP) nuclear androgen receptors (AR) were rapidly downregulated after castration. In contrast, the Dunning tumors downregulated the AR in the cancerous epithelium, but not in the surrounding stroma. Vascular regulators such as the angiopoietins, tie 2, and PDGF-Rbeta were not decreased in the stroma after castration, as observed in the VP, creating an environment that prevents vascular involution. When a tumor stroma targeted therapy inhibiting the tie 2 receptor and the PDGF-Rbeta simultaneously was added to castration it resulted in a decreased vascular density, increased tumor cell apoptosis and decreased tumor growth compared to castration alone.
CONCLUSIONS: The stroma in highly differentiated androgen sensitive Dunning tumors is apparently androgen insensitive. If this unresponsive stroma is targeted the effects of castration can be enhanced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854058     DOI: 10.1002/pros.20657

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.

Authors:  Jared A Weis; Michael I Miga; Thomas E Yankeelov
Journal:  Comput Methods Appl Mech Eng       Date:  2016-09-01       Impact factor: 6.756

2.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

3.  Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.

Authors:  You-Yi Lu; Bo Jiang; Fu-Jun Zhao; Di Cui; Qi Jiang; Jun-Jie Yu; En-Hui Li; Xiao-Hai Wang; Bang-Min Han; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2013-06-24       Impact factor: 3.285

4.  Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.

Authors:  Christina Hägglöf; Peter Hammarsten; Andreas Josefsson; Pär Stattin; Janna Paulsson; Anders Bergh; Arne Ostman
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 5.  Stroma-epithelium crosstalk in prostate cancer.

Authors:  Yi-Nong Niu; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

6.  A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.

Authors:  Zhiyong Guo; Xi Yang; Feng Sun; Richeng Jiang; Douglas E Linn; Hege Chen; Hegang Chen; Xiangtian Kong; Jonathan Melamed; Clifford G Tepper; Hsing-Jien Kung; Angela M H Brodie; Joanne Edwards; Yun Qiu
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

7.  Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.

Authors:  X Li; M Martinez-Ferrer; V Botta; C Uwamariya; J Banerjee; N A Bhowmick
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

8.  The stroma-a key regulator in prostate function and malignancy.

Authors:  Christina Hägglöf; Anders Bergh
Journal:  Cancers (Basel)       Date:  2012-05-29       Impact factor: 6.639

9.  Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.

Authors:  Jian-Ping Wu; Wen-Bin Huang; Hui Zhou; Lu-Wei Xu; Jian-Hua Zhao; Jia-Gen Zhu; Jiang-Hao Su; Hong-Bin Sun
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

10.  Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.

Authors:  Sofia Halin Bergström; Stina H Rudolfsson; Anders Bergh
Journal:  Neoplasia       Date:  2016-03       Impact factor: 5.715

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.